Inventor
LOFTSSON THORSTEINN
IS29 patents
⚠️ This page may combine multiple inventors who share the name “LOFTSSON THORSTEINN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OCULIS OPERATIONS SARL
12 patentsUS12233133B2Feb 25, 2025
Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
OCULIS OPERATIONS SARL5 citations85
US12097209B2Sep 24, 2024
Diabetic retinopathy treatment with stabilized dexamethasone
OCULIS OPERATIONS SARL3 citations84
US12090160B2Sep 17, 2024
Stabilized dexamethasone compositions
OCULIS OPERATIONS SARL4 citations84
US12090162B2Sep 17, 2024
Treatment of diabetic retinopathy
OCULIS OPERATIONS SARL3 citations78
US12383565B2Aug 12, 2025
Treatment of diabetic retinopathy with ophthalmic compositions
OCULIS OPERATIONS SARL1 citations73
US12090161B2Sep 17, 2024
Treatment of ocular inflammation
OCULIS OPERATIONS SARL2 citations70
US12521448B2Jan 13, 2026
Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
OCULIS OPERATIONS SARL0 citations61
US12403148B2Sep 2, 2025
PH stabilized ophthalmic compositions
OCULIS OPERATIONS SARL0 citations61
US12403147B2Sep 2, 2025
Treatment of ocular inflammation following ocular surgery
OCULIS OPERATIONS SARL0 citations61
US12397002B2Aug 26, 2025
PH stabilized ophthalmic dexamethasone compositions
OCULIS OPERATIONS SARL0 citations61
US12397000B2Aug 26, 2025
Stabilized ophthalmic dexamethasone compositions
OCULIS OPERATIONS SARL0 citations61
US12397001B2Aug 26, 2025
Treatment of ocular inflammation with ophthalmic compositions
OCULIS OPERATIONS SARL0 citations61
KEY PHARMA
4 patentsUS4764381AAug 16, 1988
Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
KEY PHARMA66 citations95
US4983396AJan 8, 1991
Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol
KEY PHARMA30 citations92
US4859707AAug 22, 1989
Sulfur-substituted phenylacetamides
KEY PHARMA37 citations92
US4885174ADec 5, 1989
Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol
KEY PHARMA17 citations81
OCULIS EHF
3 patentsUS8999953B2Apr 7, 2015
Cyclodextrin nanotechnology for ophthalmic drug delivery
OCULIS EHF39 citations96
US7893040B2Feb 22, 2011
Cyclodextrin nanotechnology for ophthalmic drug delivery
OCULIS EHF91 citations96
US11135311B2Oct 5, 2021
Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
OCULIS EHF16 citations91
LIPID PHARMACEUTICALS EHF
3 patentsUS8372425B2Feb 12, 2013
Fatty acids for use as a medicament
LIPID PHARMACEUTICALS EHF6 citations81
US12064455B2Aug 20, 2024
Free fatty acids and methods of manufacture and use for treating coronavirus and other viral respiratory infections
LIPID PHARMACEUTICALS EHF0 citations60
US9072714B2Jul 7, 2015
Fatty acids for use as a medicament
LIPID PHARMACEUTICALS EHF2 citations60